Bird & Bird advises Blockdaemon on its acquisition of Anyblock Analytics

Bird & Bird has advised Blockdaemon, the world’s largest blockchain infrastructure company for node management and staking, on the acquisition of German company Anyblock Analytics to extend its NFT offering and to grow their European footprint. 

Anyblock is an infrastructure platform, providing API, on-chain analytic tools, monitoring, and node hosting services across various blockchain networks. As part of the acquisition, Anyblock’s team will be joining Blockdaemon, continuing Blockdaemon’s expansion in Europe by establishing a local presence in Germany. 

The acquisition significantly strengthens Blockdaemon’s suite of offerings by expanding the capabilities of its multi-chain API suite, Ubiquity. As Blockdaemon also deepens its infrastructure support for the NFT space, the team and tooling from Anyblock will help support powering transactions behind the NFT ecosystem.

Blockdaemon was advised by the following Bird & Bird lawyers: partner Stefan Münch, associate Marcel Nurk and counsel Michael Gassner, all Corporate/M&A, Munich; partner Dr. Michael Jünemann and associate Timo Förster, both Finance & Financial Regulation, Frankfurt; partner Dr. Alexander Duisberg and associate Goekhan Kosak, both Tech & Comms/Commercial; partner Dr. Ralph Panzer, counsel Sandy Gerlach and associates Gizem Erdogan and Sven Fischer, all Employment, Munich; associate Dominic Igel, IP, Munich; partner Dr. Stephan Waldheim and associate Tamy Tietze, both EU & Competition, Düsseldorf. 

News & Deals

More News & Deals
Deal Bird & Bird advises Theon on the acquisition of Kappa Optronics

Aug 12 2025

Read More
Deal Bird & Bird advises shareholders of The Payments Association on partnership with Nineteen Group

Aug 07 2025

Read More
News Bird & Bird boosts Dispute Resolution team in Singapore

Aug 06 2025

Read More
Deal Bird & Bird acts for Cornerstone Investors in US$140m placing by Rockhopper Exploration

Aug 06 2025

Read More
Deal Bird & Bird advises ACTUM Digital on Strategic Acquisition of Kuehlhaus AG

Aug 05 2025

Read More
News Bird & Bird Advises Ratiopharm in Landmark Xarelto Patent Revocation Case

Aug 01 2025

Read More